The preoperative optimization of the Hb level with the implementation of a preoperative anemia management protocol in anemic colorectal cancer patients may be favorable for the reduction in perioperative transfusion and postoperative morbidity, which is consistent with the results of previous studies [19, 20]. The gene discussed is GSTM1; the disease is anemia.